Clémence Thiers
Stock Analyst at Stifel Nicolaus
(4.69)
# 793
Out of 5,020 analysts
70
Total ratings
38.9%
Success rate
43.8%
Average return
Main Sectors:
Stocks Rated by Clémence Thiers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: NANO Nanobiotix S.A. | Reiterated: Buy | €25.00 → €45.00 | €25.40 | +77.17% | 10 | May 22, 2026 | |
| SWX: BIOV BioVersys AG | Reiterated: Buy | CHF 70.00 | CHF 27.20 | +157.35% | 3 | Mar 31, 2026 | |
| EPA: MAAT MaaT Pharma SA | Reiterated: Buy | €19.00 | €1.03 | +1,744.66% | 18 | Mar 31, 2026 | |
| BIT: PHIL Philogen S.p.A. | Reiterated: Buy | €25.00 → €31.00 | €22.30 | n/a | 7 | Jun 25, 2025 | |
| EPA: ALSEN Sensorion SA | Reiterated: Buy | €1.50 | €7.14 | n/a | 5 | Mar 14, 2025 | |
| EPA: IPN Ipsen S.A. | Reiterated: Buy | €120.00 | €140.60 | n/a | 1 | Aug 17, 2023 | |
| EPA: VLA Valneva SE | Reiterated: Buy | €7.50 → €9.00 | €2.61 | n/a | 2 | Aug 17, 2023 | |
| EPA: ADOC Adocia SA | Reiterated: Buy | €12.00 | €2.25 | n/a | 3 | Jul 26, 2023 | |
| EPA: GBT Guerbet SA | Reiterated: Hold | €18.00 | €6.71 | n/a | 4 | Jul 21, 2023 | |
| EPA: ALCOX Nicox S.A. | Reiterated: Buy | €2.70 | €0.33 | n/a | 7 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €91.00 | €19.74 | n/a | 4 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €5.17 | €1.96 | n/a | 1 | Dec 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €7.75 | €0.09 | n/a | 1 | Dec 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €15.00 | €2.17 | n/a | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 57.00 | CHF 67.80 | n/a | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €3.10 | €1.35 | n/a | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €370.00 | €306.50 | n/a | 1 | Apr 19, 2022 |
Nanobiotix S.A.
May 22, 2026
Reiterated: Buy
Price Target: €25.00 → €45.00
Current: €25.40
Upside: +77.17%
BioVersys AG
Mar 31, 2026
Reiterated: Buy
Price Target: CHF 70.00
Current: CHF 27.20
Upside: +157.35%
MaaT Pharma SA
Mar 31, 2026
Reiterated: Buy
Price Target: €19.00
Current: €1.03
Upside: +1,744.66%
Philogen S.p.A.
Jun 25, 2025
Reiterated: Buy
Price Target: €25.00 → €31.00
Current: €22.30
Upside: n/a
Sensorion SA
Mar 14, 2025
Reiterated: Buy
Price Target: €1.50
Current: €7.14
Upside: n/a
Ipsen S.A.
Aug 17, 2023
Reiterated: Buy
Price Target: €120.00
Current: €140.60
Upside: n/a
Valneva SE
Aug 17, 2023
Reiterated: Buy
Price Target: €7.50 → €9.00
Current: €2.61
Upside: n/a
Adocia SA
Jul 26, 2023
Reiterated: Buy
Price Target: €12.00
Current: €2.25
Upside: n/a
Guerbet SA
Jul 21, 2023
Reiterated: Hold
Price Target: €18.00
Current: €6.71
Upside: n/a
Nicox S.A.
Jul 19, 2023
Reiterated: Buy
Price Target: €2.70
Current: €0.33
Upside: n/a
May 30, 2023
Reiterated: Buy
Price Target: €91.00
Current: €19.74
Upside: n/a
Dec 27, 2022
Reiterated: Buy
Price Target: €5.17
Current: €1.96
Upside: n/a
Dec 27, 2022
Reiterated: Buy
Price Target: €7.75
Current: €0.09
Upside: n/a
Sep 23, 2022
Reiterated: Buy
Price Target: €15.00
Current: €2.17
Upside: n/a
Sep 7, 2022
Reiterated: Buy
Price Target: CHF 57.00
Current: CHF 67.80
Upside: n/a
Aug 8, 2022
Downgraded: Hold
Price Target: €3.10
Current: €1.35
Upside: n/a
Apr 19, 2022
Reiterated: Buy
Price Target: €370.00
Current: €306.50
Upside: n/a